- Home
- GLSI vs RMAX Comparison
GLSI vs RMAX Comparison
Compare GLSI & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- RMAX
- Stock Information
- Founded
- GLSI 2006
- RMAX 1973
- Country
- GLSI United States
- RMAX United States
- Employees
- GLSI N/A
- RMAX N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- RMAX Real Estate
- Sector
- GLSI Health Care
- RMAX Finance
- Exchange
- GLSI Nasdaq
- RMAX Nasdaq
- Market Cap
- GLSI 134.6M
- RMAX 151.5M
- IPO Year
- GLSI 2020
- RMAX 2013
- Fundamental
- Price
- GLSI $10.08
- RMAX $8.18
- Analyst Decision
- GLSI Strong Buy
- RMAX Hold
- Analyst Count
- GLSI 1
- RMAX 2
- Target Price
- GLSI $39.00
- RMAX $9.75
- AVG Volume (30 Days)
- GLSI 54.6K
- RMAX 218.6K
- Earning Date
- GLSI 08-13-2025
- RMAX 07-29-2025
- Dividend Yield
- GLSI N/A
- RMAX N/A
- EPS Growth
- GLSI N/A
- RMAX N/A
- EPS
- GLSI N/A
- RMAX 0.44
- Revenue
- GLSI N/A
- RMAX $303,865,000.00
- Revenue This Year
- GLSI N/A
- RMAX N/A
- Revenue Next Year
- GLSI N/A
- RMAX $1.64
- P/E Ratio
- GLSI N/A
- RMAX $18.84
- Revenue Growth
- GLSI N/A
- RMAX N/A
- 52 Week Low
- GLSI $8.06
- RMAX $6.90
- 52 Week High
- GLSI $17.00
- RMAX $14.31
- Technical
- Relative Strength Index (RSI)
- GLSI 53.55
- RMAX 53.45
- Support Level
- GLSI $8.97
- RMAX $8.18
- Resistance Level
- GLSI $11.52
- RMAX $8.49
- Average True Range (ATR)
- GLSI 0.53
- RMAX 0.31
- MACD
- GLSI 0.14
- RMAX -0.02
- Stochastic Oscillator
- GLSI 49.53
- RMAX 33.33
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.